Baxter International, Inc.
One Baxter Parkway
About Baxter International, Inc.
Baxter touches millions of lives every day. Our products and services are essential building blocks of healthcare.
You’ll find Baxter’s products and therapies on nearly every floor, in every department, in almost every hospital worldwide. You’ll find us in clinics and in the home. Patients and providers rely on Baxter for lifesaving renal and medical products, including intravenous (IV) solutions, systems and administrative sets, IV infusion parenteral nutrition, perioperative care, pharmacy devices and software, acute renal care, and home and in-center dialysis.
Our mission to save and sustain lives inspires our work and our commitment to expanding access to care, providing cost-effective healthcare solutions, delivering quality products and advancing innovations for the world.
Our commitment to our mission means we are there when patients and healthcare professionals need us, during the critical moments that matter most.
CEO: José (Joe) E. Almeida
CMO: James R. Gavin III
CTO: Uma Chowdhry
CFO: Peter Hellman
Please click here for Baxter job opportunities.
FOLLOW BAXTER INTERNATIONAL:
Tweets by Baxer International
762 articles with Baxter International, Inc.
Baxter International Inc., a leading global medical products company, will present at the 2019 Bank of America Merrill Lynch Health Care Conference in Las Vegas on May 15, 2019.
Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced that it has received U.S. Food and Drug Administration (FDA) approval for faster preparation of its leading hemostatic product, Floseal Hemostatic Matrix, at the 2019 Association of periOperative Registered Nurses (AORN) Global Surgical Conference and Expo.
Baxter International Inc., a leading global medical products company, will host a webcast of its Annual Meeting of Stockholders on Tuesday, May 7, 2019 at 9 a.m. Central Daylight Time.
Reinforces the company’s efforts to innovate nutrition formulations and delivery mechanisms to meet the needs of patients
Baxter and bioMérieux Announce Collaboration to Improve Identification and Treatment of Acute Kidney Injury
Baxter International Inc. announced an agreement to develop future biomarkers with the goal to rapidly identify and inform treatment of acute kidney injury (AKI).
Baxter International Inc., a leading global medical products company, will host a conference call to discuss its first quarter 2019 financial results on Thursday, April 25, 2019, at 7:30 a.m. Central Time.
First and only premixed presentation of eptifibatide available in a flexible container Eptifibatide is the latest addition to Baxter’s broad line of ready-to-use medications intended to help enhance patient safety and support pharmacy efficiency
Baxter Honored as a 2019 “Top Company for Executive Women” by the National Association for Female Executives
From board representation to pay equity, company promotes an ongoing commitment to advance women in leadership
Baxter International Inc., a leading global medical products company, announced that its Board of Directors has declared a quarterly cash dividend of $0.19 per share of common stock.
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Barclays Global Healthcare Conference in Miami, Fla. on March 12, 2019.
NantHealth has validated successful DeviceConX™ integration with Baxter’s Prismaflex system, used to treat critically-ill patients in the ICU
Fourth-quarter revenue of $2.8 billion increased 2 percent on a reported basis and 5 percent on an operational basis
Baxter International, Inc., a leading global medical products company, will present at the 8th Annual SVB Leerink Global Healthcare Conference in New York, NY on Thursday, February 28, 2019.
Baxter Announces 5 Million Home Dialysis Treatments Managed Globally with Sharesource Remote Patient Management
Sharesource remote patient management – now available in 40 countries – is evolving peritoneal dialysis practice management
First patients have been enrolled in the clinical trial for next generation dialysis technology
The Patient Safety Movement Foundation (PSMF) announced today that Baxter International Inc. (NYSE:BAX), a global medical products company, has signed the PSMF’s Open Data Pledge as the 89th company to demonstrate the importance of data sharing to improving patient safety.
Baxter Launches Curved Applicator for Floseal, Expanding Use of Leading Hemostat During ENT Procedures
New applicator provides surgeons with greater control during ENT surgeries to help foster improved outcomes for patients
Addition of industry veterans reflects ongoing board refreshment efforts and commitment to further diversification
Baxter International Inc. (NYSE:BAX), a global leader in clinical nutrition, is collaborating with the European Foundation for the Care of Newborn Infants (EFCNI) to raise awareness for the new EFCNI standards that address the disparities in newborn care in Europe
Baxter International Inc. will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco. José (Joe) E. Almeida, Baxter’s chairman and chief executive officer, is scheduled to present on Monday, January 7, 2019 at 10 a.m. Pacific Time.